Wuhan Greenovo Biotechnology Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Wuhan Greenovo Biotechnology Co., Ltd. - overview
Established
2012
Location
Wuhan, Hubei, China
Primary Industry
Medical Devices & Equipment
About
Established in 2012 and based in Wuhan, China. Wuhan Greenovo Biotechnology Co. , Ltd. is a biomedical material manufacturer that focuses on hemostasis and wound care.
In July 2015, the company raised CNY 10 million in series A funding. In August 2017, the firm was listed on the National Equities Exchange and Quotations. Its stock code is 871920. In October 2024, it raised CNY 99.
99 million in venture funding. The company provides medical care experience for clients such as medical staff, patients, medical research institutions and enterprises. The business of the company includes research and development, production and sales of new biomedical materials. The company's products include military first aid hemostasis, intraoperative hemostasis, wound care, dental hemostasis and home care.
The company's products focuses on cardiovascular, anesthesiology and intensive care, general surgery. The company’s revenue is generated by providing biomedical materials.
Current Investors
Hubei Gaotou Xinlong Investment Management, Rivercity Investment, Guangzhou Cherami Sun Tour Equity Investment Management
Primary Industry
Medical Devices & Equipment
Sub Industries
Outsourcing, Medical Supplies, Therapeutic Devices
Website
www.gnovo.com
Verticals
Manufacturing
Company Stage
Growth Stage/Expansion
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.